Latest / CareTalk: Healthcare. Unfiltered.
FDA Approves Leqembi: What You Should Know
Send us Fan Mail
FDA just approved Leqembi, a drug to slow the cognitive decline of Alzheimer’s patients, and Medicare has agreed to pay for it. Is it time for patients, families and physicians to be excited? Or do we need to temper our hopes?
Dive deeper into this episode and read our report, Leqembi: What to Know About the New Alzheimer's Drug. https://www.caretalkpodcast.com/post/leqembi-what-to-know-about-the-new-alzheimer-s-drug
ABOUT CARETALK
CareTalk is a weekly podcast that provides an incisive, no B.S. view of the US healthcare industry. Join co-hosts John Driscoll (President U.S…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.